SCHEMBL21923002

SCHEMBL21923002

CCCC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.85
MAPT P10636 2/20 0.85
MEN1 O00255 2/20 0.85
KMT2A Q03164 2/20 0.85
TTPA P49638 2/20 0.85
GSTP1 P09211 1/20 0.85
USP2 O75604 1/20 0.85
THRB P10828 1/20 0.85
CYP2C9 P11712 1/20 0.85
CYP2C19 P33261 1/20 0.85
NR1I2 O75469 3/20 0.83
ALOX5 P09917 2/20 0.77
PDE4A P27815 1/20 0.60
PDE3A Q14432 1/20 0.60
GSTO1 P78417 2/20 0.59
PSEN1 P49768 2/20 0.58
PTPN1 P18031 1/20 0.55
CYP4F2 P78329 1/20 0.51
AKT1 P31749 2/20 0.48
PDPK1 O15530 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11036634 0.94 LMNA (0.83) LMNAMAPTMEN1KMT2ATTPA
Alpha-Tocopherol SCHEMBL27829065 0.92 LMNA (0.91) LMNAMAPTMEN1KMT2ATTPA
Alpha-Tocopherol SCHEMBL28072150 0.92 LMNA (0.95) LMNAMAPTMEN1KMT2ATTPA
Alpha-Tochopherol SCHEMBL14315133 0.92 LMNA (1.00) LMNAMAPTMEN1KMT2ATTPA
Alpha-Tocopherol SCHEMBL20817063 0.92 LMNA (1.00) LMNAMAPTMEN1KMT2ATTPA
Alpha-Tocopherol SCHEMBL3059188 0.92 LMNA (1.00) LMNAMAPTMEN1KMT2ATTPA
SCHEMBL8084077 0.92 LMNA (1.00) LMNAMAPTMEN1KMT2ATTPA
Alpha-Tocopherol SCHEMBL17874901 0.92 LMNA (1.00) LMNAMAPTMEN1KMT2ATTPA
Alpha-Tocopherol SCHEMBL14167439 0.92 LMNA (1.00) LMNAMAPTMEN1KMT2ATTPA
Alpha-Tocopherol SCHEMBL14297170 0.92 LMNA (1.00) LMNAMAPTMEN1KMT2ATTPA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131498-A1 POLYNUCLEOTIDES ENCODING METHYLMALONYL-COA MUTASE MODERNATX, INC. 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131498-A1 POLYNUCLEOTIDES ENCODING METHYLMALONYL-COA MUTASE POLM, MCM6, MCM3 LMNA 579/4885MAPT 3654/4885MEN1 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.